Cargando…
NAFLD Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications and the Trends in the United States
Nonalcoholic fatty liver disease (NAFLD) is a hepatic manifestation of metabolic syndrome. The spread of obesity worldwide in pandemic proportions has led to a rapid rise of NAFLD in developed and developing countries alike. There are no approved pharmacological agents to treat steatohepatitis or ad...
Autores principales: | Gadiparthi, Chiranjeevi, Spatz, Moshe, Greenberg, Simi, Iqbal, Umair, Kanna, Sowjanya, Satapathy, Sanjaya K, Broder, Arkady, Ahmed, Aijaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438346/ https://www.ncbi.nlm.nih.gov/pubmed/32832402 http://dx.doi.org/10.14218/JCTH.2020.00014 |
Ejemplares similares
-
Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates
por: Gadiparthi, Chiranjeevi, et al.
Publicado: (2018) -
Nonalcoholic Fatty Liver Disease: Epidemiology, Liver Transplantation Trends and Outcomes, and Risk of Recurrent Disease in the Graft
por: Liu, Andy, et al.
Publicado: (2018) -
Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation
por: Cholankeril, George, et al.
Publicado: (2019) -
Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management
por: Chauhan, Ranjit, et al.
Publicado: (2018) -
Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease
por: Dibba, Pratima, et al.
Publicado: (2018)